Getting to That Point

Clinicians need to prepare for the onslaught of whole-genome sequencing data, the National Institutes of Health Director Francis Collins said at a personalized medicine symposium. According to MedPage Today, Collins says that single-gene tests will be replaced by whole-genome sequencing within a handful of years. He also said that there needs to be a database where clinicians can easily look up what's known about a gene and its mutations, particularly in the context of cancer risk.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.